Replies to post #659573 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Whether the PIM or the HE, both were very broad, so i think it is likely they get a broad designation for relevant brain tumor indications. ...

The PIM designation is the gateway to the UK EAMS program that is specifically designed to allow drugs to be marketed in the window between P3 results and MAA approval.

And here we have crickets on EAMS. Why?